Drug or treatment
Mezagitamab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Mezagitamab that are recruiting, at sites in 29 countries (most in China (4), Japan (4), United States (4)). By phase: Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 29Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Mezagitamab for adults with late antibody-mediated rejection after kidney transplant | Phase 2 | Los Angeles, California and 34 other locations | Recruiting | May 29, 2026 |
| Mezagitamab for adults with IgA nephropathy | Phase 3 | Birmingham, Alabama and 185 other locations | Recruiting | May 9, 2025 |
| Follow-up mezagitamab treatment for adults with chronic primary immune thrombocytopenia | Phase 3 | Hot Springs, Arkansas and 117 other locations | Recruiting | Apr 29, 2025 |
| Mezagitamab treatment for adults with chronic immune thrombocytopenia | Phase 3 | Hot Springs, Arkansas and 123 other locations | Recruiting | Dec 9, 2024 |
All recruiting trials (4)
-
Mezagitamab for adults with late antibody-mediated rejection after kidney transplant
Mezagitamab is being tested to see if it is safe and helps kidney transplant patients with late antibody-mediated rejection, compared with a placebo.
-
Mezagitamab for adults with IgA nephropathy
This trial will test if mezagitamab can reduce protein in the urine of adults with primary IgA nephropathy.
-
Follow-up mezagitamab treatment for adults with chronic primary immune thrombocytopenia
This follow-up will try giving mezagitamab longer-term to adults with chronic primary ITP who completed earlier mezagitamab studies to see if it stays safe, is tolerated, and helps maintain platelet responses.
-
Mezagitamab treatment for adults with chronic immune thrombocytopenia
This study is testing if a new treatment called mezagitamab can help adults with chronic immune thrombocytopenia keep their platelet counts stable compared to a placebo.
Quick answers
How many clinical trials of Mezagitamab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 29 countries. The most sites are in China (4 trials), Japan (4 trials), United States (4 trials), Australia (3 trials), Hong Kong (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.